SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001698530-24-000047
Filing Date
2024-06-06
Accepted
2024-06-06 16:16:18
Documents
80
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A xcur-20230331.htm   iXBRL 10-Q/A 1018691
2 EX-31.1 exicureexhibit311-33123qa.htm EX-31.1 7755
3 EX-31.2 exicureexhibit312-33123qa.htm EX-31.2 7767
4 EX-32.1 exicureexhibit321-33123qa.htm EX-32.1 8246
  Complete submission text file 0001698530-24-000047.txt   5837356

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20230331.xsd EX-101.SCH 52315
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xcur-20230331_cal.xml EX-101.CAL 57802
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xcur-20230331_def.xml EX-101.DEF 215378
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20230331_lab.xml EX-101.LAB 576739
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20230331_pre.xml EX-101.PRE 404586
84 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20230331_htm.xml XML 685925
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-39011 | Film No.: 241025263
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)